GTX-104

· Grace Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GTX-104, covering 2024-10-01 to 2024-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAH [Phase 3]